F-18 FDG positron emission tomography findings in primary pancreatic lymphoma

Clin Nucl Med. 2004 Sep;29(9):574-5. doi: 10.1097/01.rlu.0000135269.00531.f8.

Abstract

The usefulness of F-18 2'-deoxy-2-fluoro-D-glucose (FDG) positron emission tomography (PET) has been well established for lymphoma staging. Although involvement of the pancreas occurs in more than one third of patients with non-Hodgkin lymphoma, primary lymphoma of the pancreas accounts for less than 1% of extranodal non-Hodgkin lymphomas. Because patients with primary pancreatic lymphoma require a different therapeutic approach and have a better prognosis than those with pancreatic adenocarcinoma, the accurate diagnosis is important. However, conventional imaging modalities cannot differentiate between adenocarcinoma and other less common neoplasms such as lymphoma. We report a 67-year-old man who had a primary pancreatic lymphoma in which FDG PET imaging revealed round, intense FDG uptake in the center of the midabdomen.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Fluorodeoxyglucose F18*
  • Humans
  • Lymphoma, B-Cell / diagnostic imaging*
  • Male
  • Pancreatic Neoplasms / diagnostic imaging*
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18